Delhi High Court has suspended the public notices issued by the Indian patent office with regard to extension of due dates in view of the lockdown in India and directed the Indian Patent Office (IPO) to act according to the Supreme Court’s direction. In the matter of SUO MOTU WRIT…

 India was in a complete lockdown from 25th March 2020 to 3rd May, 2020 (lockdowns 1 and 2) and Indian patent Office was closed until 3rd May 2020. In order to curtail the spread of COVID-19, the Indian Government on 1st May, 2020 decided to extend the nation-wide lockdown (lockdown-3)…

Indian Patent Office (IPO) by the order of Ministry of Home Affairs dated 15th April, 2020, started functioning from April 20, 2020 with full staff of the rank of Deputy Controller and above and one-third staff strength up to rank of Assistant Controller on all workings days. The Patent Office…

India was in a complete lockdown from 25 March 2020 to 14 April, 2020 (lockdown 1). In order to curtail the spread of COVID-19, the Indian Government on 14th April, 2020 decided to extend the nation-wide lockdown (lockdown-2) until 3rd May 2020. In furtherance of the lockdown, the Ministry of…

In view of the advisory issued by Ministry of Health & Family Welfare, Govt. of India and concerns raised by Stakeholders regarding COVID-19 outbreak, the Indian Patent Office has notified that all in person hearings in Patents and Designs matters scheduled on or before 15th April, 2020 will be done…

The Indian Patent Office (IPO) and Japan Patent Office (JPO) started a bilateral Patent Prosecution Highway Program (PPH). The filing of request under this Program commenced from 5th December 2019 as notified on 4th December 2019. After scrutiny of 100 requests received, 56 requests were accepted by IPO and the…

The patent application No. 1430/DELNP/2011 entitled “DIOXA-BICYCLO[3.2.1.]OCTANE-2,3,4-TRIOL DERIVATIVES” has been granted to Pfizer Inc. by the Indian Patent Office. A pre-grant opposition u/S 25(1) with regard to this application was filed by Mr. Antony David on 20/08/2018. A hearing was held in the matter on 05/11/2019. The compound claimed in the…

The Delhi High Court in ASTRAZENECA Vs. Emcure Pharmaceuticals limited and ASTRAZENECA Vs. MSN Laboratories Limited has not granted injunction to the Plaintiff’s. The Hon’ble Court has held that the claim of the plaintiffs, that the compound TICAGRELOR is produced as per IN’209907 even though its formula is covered under…

Hon’ble IPAB chairman , Justice Manmohan Singh,  launched the Website of Intellectual Property Appellate Board, Department for Promotion of Industry and Internal Trade, to make the Board accessible to the common public and end users. The website can be accessed at :- http://ipab.gov.in/index.php .

In Ferid Allani vs. Union of India (W.P. (C) No. 7 of 2014), the Hon’ble Delhi High Court (DHC) has disposed of the Writ Petition, setting aside the impugned order of the Hon’ble IPAB (Intellectual Property Appellate Board) and remanding  back the case to the patent office for reconsideration. A…